Japan · Delayed Price · Currency is JPY Human Metabolome Technologies Company Description
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
The company provides metabolome analysis services; and global profiling, targeted panels, flux analysis, and lipidomics services.
The company offers solutions for cancer metabolism; metabolic flux analysis; functional food; neurobiology research; renal and disease markers; skin and dermo-metabolomics; T-cell and B-cell metabolism; bacterial, fungal, and algae metabolism; tastant profiling; biomarker discovery, mitochondrial metabolism; patient profiling and subtyping; cellular engineering; and biomanufacturing and metabolomics applications.
Human Metabolome Technologies, Inc. has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology.
The company was incorporated in 2003 and is based in Tsuruoka, Japan.
| Country | Japan |
| Founded | 2003 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 65 |
| CEO | Yasuhiro Ohata |
Contact Details
Address: 246-2 Mizukami Kakuganji Tsuruoka, 997-0052 Japan | |
| Phone | 81 2 3525 1447 |
| Website | humanmetabolome.com |
Stock Details
| Ticker Symbol | 6090 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | JPY |
| ISIN Number | JP3794530000 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Yasuhiro Ohata | Chief Executive Officer |
| Yasuhiro Ohata | Chief Financial Officer |
| Kenjiro Kami | Chief Operating Officer |